Dextromethorphan's Psychedelic Potential: Implications and Risks

Introduction to Dextromethorphan's Psychedelic Potential

Dextromethorphan (DXM), commonly known as a cough suppressant, is under scrutiny for its potential psychedelic properties. A systematic review published in June 2026 in PubMed examines these properties and suggests that DXM could be repurposed for mental health treatments. The review aggregates existing research to evaluate DXM's effects beyond its traditional use.

Mechanisms and Context

DXM acts on the central nervous system, primarily as an NMDA receptor antagonist. This mechanism is similar to other psychedelics, which may explain its potential for altering perception and mood. The review highlights that while DXM is legally available over-the-counter in many jurisdictions, its psychoactive effects at higher doses warrant careful consideration.

Research and Policy Implications

The findings of this review could significantly influence future research directions. By identifying DXM's potential as a psychedelic, researchers might explore its use in treating conditions such as depression, anxiety, and PTSD. Policymakers and regulatory bodies may need to consider revising guidelines to accommodate new clinical trials that explore these applications.

Risks and Unknowns

Despite the promising potential, the review emphasizes the need for comprehensive safety and efficacy evaluations. DXM's side effects, especially at high doses, include confusion, dizziness, and potential for abuse. These risks must be carefully managed in any clinical trial setting. Additionally, the long-term effects of DXM as a psychedelic remain largely unknown.

Looking Forward

As interest in psychedelic research grows, DXM could become a focal point for new studies and trials. The systematic review serves as a call to action for researchers to delve deeper into understanding its full range of effects and therapeutic potential. Collaboration between neuroscientists, clinicians, and policymakers will be crucial to navigate the complexities of repurposing DXM for mental health applications.